Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type

Condition:   Agitation Interventions:   Drug: 12 cm2 - 2 Active DMTS Patches;   Drug: 6 cm2 - 1 Active and 1 Placebo DMTS Patches;   Drug: Placebo - 2 Placebo DMTS Patches Sponsor:   Teikoku Pharma USA, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials